Our study aimed to address this knowledge gap by assessing the prognostic value of YKL-40 in relation to cancers associated with obesity and type 2 diabetes in a contemporary cohort of individuals newly diagnosed with type 2 diabetes. This evidence concerns the gene CHI3L1 and cancer.